案例:Pembrolizumab诱导的心肌炎和完全心脏阻塞的一个案例
Janak Adhikari1, Priyadarshani Sharma1, Eddy Karnabi2
1Department of Internal Medicine, Eastern Maine Medical Center, Bangor, ME, USA.
概括
作为免疫检查点抑制剂的 pembrolizumab 很少会导致心脏问题. 这一案例突出了pembrolizumab诱导的心肌炎和持续的三度心脏阻塞,强调了对心脏监测的需要.
科学领域:
- 心脏病学 心脏病学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 免疫检查点抑制剂 (ICI) 如 pembrolizumab 越来越多地用于癌症治疗.
- 虽然有效,但ICI很少会导致影响各种器官的免疫相关不良事件.
- 虽然ICI的心脏副作用并不常见,但可能是严重的.
相关概念视频
Disturbances in Heart Rhythm
928
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
928
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
405
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
405


